AChR-MG patients, excluding TAMG patients, carried the PTPN22 T allele significantly more frequently than HC (9.5 vs. 4.1%, OR: 2.5, 95% confidence interval [CI]: 1.2–5.1, p = 0.013, Table 2). Here, PTPN22 is linked to myasthenia gravis.